{"id":"https://openalex.org/W4362494570","doi":"https://doi.org/10.1158/1535-7163.c.6537621","title":"Data from Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA)","display_name":"Data from Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA)","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362494570","doi":"https://doi.org/10.1158/1535-7163.c.6537621"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.6537621","doi":"https://doi.org/10.1158/1535-7163.c.6537621","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6537621","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.c.6537621","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015483526","display_name":"Michael J. Wagner","orcid":"https://orcid.org/0000-0002-0753-9282","observed_orcids":["https://orcid.org/0000-0002-0753-9282"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael J. Wagner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Rahul Mitra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rahul Mitra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108666496","display_name":"Mark J. McArthur","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark J. McArthur","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109842994","display_name":"Wallace B. Baze","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wallace Baze","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112905356","display_name":"Kirstin F. Barnhart","orcid":"https://orcid.org/0009-0009-6762-7282","observed_orcids":["https://orcid.org/0009-0009-6762-7282"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kirstin Barnhart","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027588399","display_name":"Sherry Y. Wu","orcid":"https://orcid.org/0000-0002-6051-4252","observed_orcids":["https://orcid.org/0000-0002-6051-4252"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sherry Y. Wu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010129570","display_name":"Cristian Rodriguez\u2010Aguayo","orcid":"https://orcid.org/0000-0002-7880-7723","observed_orcids":["https://orcid.org/0000-0002-7880-7723"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cristian Rodriguez-Aguayo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072661022","display_name":"Xinna Zhang","orcid":"https://orcid.org/0000-0003-4118-2245","observed_orcids":["https://orcid.org/0000-0003-4118-2245"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xinna Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009234043","display_name":"Robert Louis Coleman","orcid":"https://orcid.org/0000-0001-9343-8754","observed_orcids":["https://orcid.org/0000-0001-9343-8754"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert L. Coleman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023542865","display_name":"Gabriel Lopez\u2010Berestein","orcid":"https://orcid.org/0000-0002-0366-0720","observed_orcids":["https://orcid.org/0000-0002-0366-0720"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriel Lopez-Berestein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100640276","display_name":"Anil K. Sood","orcid":"https://orcid.org/0000-0002-5415-9901","observed_orcids":["https://orcid.org/0000-0002-5415-9901"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anil K. Sood","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sirna-delivery","display_name":"siRNA delivery","score":0.8199999928474426},{"id":"https://openalex.org/keywords/nanoliposomes","display_name":"nanoliposomes","score":0.8069999814033508},{"id":"https://openalex.org/keywords/dopc","display_name":"DOPC","score":0.8140000104904175},{"id":"https://openalex.org/keywords/epha2","display_name":"EphA2","score":0.9369999766349792},{"id":"https://openalex.org/keywords/preclinical-safety-evaluation","display_name":"preclinical safety","score":0.7760000228881836},{"id":"https://openalex.org/keywords/no-observed-adverse-effect-level","display_name":"no-observed-adverse-effect level","score":0.9039999842643738},{"id":"https://openalex.org/keywords/rhesus-macaques","display_name":"rhesus monkeys","score":0.7739999890327454},{"id":"https://openalex.org/keywords/mouse-toxicity","display_name":"mouse toxicity","score":0.5830000042915344},{"id":"https://openalex.org/keywords/organ-toxicity","display_name":"organ toxicity","score":0.6069999933242798},{"id":"https://openalex.org/keywords/hemolysis","display_name":"hemolysis","score":0.6869999766349792},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.5120000243186951},{"id":"https://openalex.org/keywords/hematological-parameters","display_name":"hematological parameters","score":0.4869999885559082},{"id":"https://openalex.org/keywords/systemic-sirna-delivery","display_name":"systemic siRNA delivery","score":0.5659999847412109}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6552035212516785},{"id":"https://openalex.org/C2776190711","wikidata":"https://www.wikidata.org/wiki/Q7398663","display_name":"Safety pharmacology","level":3,"score":0.5726028084754944},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5715891122817993},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.558184027671814},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.55024653673172},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5467797517776489},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.5439576506614685},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.4774128198623657},{"id":"https://openalex.org/C2777495288","wikidata":"https://www.wikidata.org/wiki/Q1755926","display_name":"No-observed-adverse-effect level","level":3,"score":0.46469590067863464},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.4549117386341095},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3411375880241394},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3136753439903259},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30588218569755554},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.19246181845664978},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.c.6537621","doi":"https://doi.org/10.1158/1535-7163.c.6537621","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6537621","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.c.6537621.v1","doi":"https://doi.org/10.1158/1535-7163.c.6537621.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6537621.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.6537621","doi":"https://doi.org/10.1158/1535-7163.c.6537621","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6537621","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2591778805","https://openalex.org/W2500551752","https://openalex.org/W2129825215","https://openalex.org/W4256169941","https://openalex.org/W71257142","https://openalex.org/W2053623878","https://openalex.org/W4392679001","https://openalex.org/W2511706330","https://openalex.org/W6991057783","https://openalex.org/W1971975619"],"abstract_inverted_index":{"Abstract":[0],"To":[1],"address":[2],"the":[3,119,177,196],"need":[4],"for":[5,11,61,134],"efficient":[6],"and":[7,32,51,59,66,77,97,126,200],"biocompatible":[8],"delivery":[9],"systems":[10],"systemic":[12],"siRNA":[13],"delivery,":[14],"we":[15,24],"developed":[16],"1,2-Dioleoyl-sn-Glycero-3-Phosphatidylcholine":[17],"(DOPC)":[18],"nanoliposomal":[19],"EphA2-targeted":[20],"therapeutic":[21],"(EPHARNA).":[22],"Here,":[23],"performed":[25],"safety":[26],"studies":[27],"of":[28,37,63,71,187],"EPHARNA":[29,38,72,104,135,154,206,213],"in":[30,44,75,86,117,147,164,176,192,227],"murine":[31],"primate":[33],"models.":[34],"Single":[35],"dosing":[36,70],"was":[39,73,190],"tested":[40,74],"at":[41,82,217],"5":[42],"concentrations":[43],"mice":[45,76],"(N":[46],"=":[47],"15":[48],"per":[49],"group)":[50],"groups":[52],"were":[53,100,115,207],"sacrificed":[54],"on":[55,91],"days":[56],"1,":[57],"14,":[58],"28":[60,127],"evaluation":[62],"clinical":[64,239],"pathology":[65],"organ":[67,98],"toxicity.":[68],"Multiple":[69],"Rhesus":[78,181],"macaques":[79],"twice":[80,151],"weekly":[81,152],"two":[83],"dose":[84],"levels":[85],"each":[87],"model.":[88],"Possible":[89],"effects":[90],"hematologic":[92],"parameters,":[93],"serum":[94],"chemistry,":[95],"coagulation,":[96],"toxicity":[99],"assessed.":[101],"Following":[102],"single-dose":[103],"administration":[105],"to":[106,156,160,170,184,205,233],"mice,":[107],"no":[108],"gross":[109],"pathologic":[110],"or":[111,123],"dose-related":[112,166],"microscopic":[113],"findings":[114],"observed":[116],"either":[118],"acute":[120],"(24":[121],"hours)":[122],"recovery":[124],"(14":[125],"days)":[128],"phases.":[129],"The":[130],"no-observed-adverse-effect":[131],"level":[132],"(NOAEL)":[133],"is":[136,214],"considered":[137],">225":[138],"\u03bcg/kg":[139],"when":[140],"administered":[141],"as":[142],"a":[143,158,165,172],"single":[144],"injection":[145],"intravenously":[146],"CD-1":[148],"mice.":[149,179],"With":[150],"injection,":[153],"appeared":[155,169],"stimulate":[157],"mild":[159,173],"moderate":[161,185],"inflammatory":[162],"response":[163],"fashion.":[167],"There":[168],"be":[171],"hemolytic":[174],"reaction":[175],"female":[178],"In":[180],"macaques,":[182],"minimal":[183],"infiltration":[186],"mononuclear":[188],"cells":[189],"found":[191],"some":[193],"organs":[194],"including":[195],"gastrointestinal":[197],"tract,":[198],"heart,":[199],"kidney.":[201],"No":[202],"differences":[203],"attributed":[204],"observed.":[208],"These":[209,221],"results":[210],"demonstrate":[211],"that":[212],"well":[215],"tolerated":[216],"all":[218],"doses":[219],"tested.":[220],"data,":[222],"combined":[223],"with":[224],"previously":[225],"published":[226],"vivo":[228],"validation":[229],"studies,":[230],"have":[231],"led":[232],"an":[234],"ongoing":[235],"first-in-human":[236],"phase":[237],"I":[238],"trial":[240],"(NCT01591356).":[241],"Mol":[242],"Cancer":[243],"Ther;":[244],"16(6);":[245],"1114\u201323.":[246],"\u00a92017":[247],"AACR.":[248]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}